One study by Wang et al. also showed another risk factor of HCC in HBV-infected individuals to be the hypomethylated MDM2 promoter, where it is stated that its gene products contribute significantly to HCC and encourage tumor growth. This evidence concerns the gene MDM2 and neoplasm.